Precision BioSciences is a gene editing company that develops therapies for genetic disorders and cancer treatment. Their platform, ARCUS, works to cure genetic disorders, while their ex vivo allogeneic CAR T immunotherapy aims to destroy cancer cells using genetically-engineered T cells. The company also has license agreements with other organizations as they continue to expand their development of gene editing therapies.